The changing face of Familial Mediterranean Fever
- 1 December 1996
- journal article
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 26 (3), 612-627
- https://doi.org/10.1016/s0049-0172(96)80012-6
Abstract
Familial Mediterranean fever (FMF) is a genetic disease characterized by painful febrile "attacks" of serositis and the development of amyloidosis. Although FMF has been extensively studied and described, new data have accumulated during the last decade. This report gives an update, focusing specifically on (1) newly characterized manifestations, such as acute scrotal "attacks," protracted febrile myalgia, and spondyloarthropathy; (2) progress made in the diagnosis and treatment of FMF-amyloidosis; (3) experience acquired with colchicine, establishing its safety in common practice, childhood, conception, and pregnancy; (4) colchicine's role in the prevention and treatment of FMF-amyloidosis; (5) new laboratory findings; and (6) new considerations in the differential diagnosis. The most important achievement in recent years, however, is the mapping of the FMF susceptibility gene to chromosome 16p, a finding that raises hopes for prompt cloning of the gene and elucidation of the mechanisms involved in FMF expression.Keywords
This publication has 94 references indexed in Scilit:
- Biologic and clinical advances in familial Mediterranean feverCritical Reviews in Oncology/Hematology, 1995
- Neurologic manifestations in familial Mediterranean feverPediatric Neurology, 1993
- Breast-feeding during colchicine therapy for familial Mediterranean feverThe Journal of Pediatrics, 1991
- Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis)The Journal of Pediatrics, 1990
- Colchicine Myopathy and NeuropathyNew England Journal of Medicine, 1987
- Syndrome of periodic fever, pharyngitis, and aphthous stomatitisThe Journal of Pediatrics, 1987
- Colchicine in the Prevention and Treatment of the Amyloidosis of Familial Mediterranean FeverNew England Journal of Medicine, 1986
- C5a-Inhibitor Deficiency in Peritoneal Fluids from Patients with Familial Mediterranean FeverNew England Journal of Medicine, 1984
- Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever)Digestive Diseases and Sciences, 1982
- Familial Mediterranean Fever — A congenital disorder of exaggerated response to endogenous interferon?Medical Hypotheses, 1982